Corticosteroid treatment in severe community-acquired pneumonia: duration of treatment affects control of systemic inflammation and clinical improvement.

PubWeight™: 0.82‹?›

🔗 View Article (PMID 21688102)

Published in Intensive Care Med on June 18, 2011

Authors

Qurrat-Ul-Ain Nawab, Emmel Golden, Marco Confalonieri, Reba Umberger, G Umberto Meduri

Articles by these authors

Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. Chest (2007) 7.49

Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med (2008) 5.30

Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review. JAMA (2009) 4.73

Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. Am J Respir Crit Care Med (2004) 4.58

H1N1 influenza A virus-associated acute lung injury: response to combination oseltamivir and prolonged corticosteroid treatment. Intensive Care Med (2009) 3.13

Evaluation of patient skin breakdown and comfort with a new face mask for non-invasive ventilation: a multi-center study. Intensive Care Med (2002) 2.46

Hemodynamic monitoring in shock and implications for management. International Consensus Conference, Paris, France, 27-28 April 2006. Intensive Care Med (2007) 2.18

Effects of methylprednisolone infusion on markers of inflammation, coagulation, and angiogenesis in early acute respiratory distress syndrome. Crit Care Med (2012) 1.64

Increased number and expertise of italian respiratory high-dependency care units: the second national survey. Respir Care (2011) 1.62

High-frequency percussive ventilation improves perioperatively clinical evolution in pulmonary resection. Crit Care Med (2009) 1.48

Long-term azithromycin use in patients with chronic obstructive pulmonary disease and tracheostomy. Pulm Pharmacol Ther (2009) 1.23

Proteomic analysis of inflammatory biomarkers in bronchoalveolar lavage. Proteomics (2006) 1.15

Costs of the COPD. Differences between intensive care unit and respiratory intermediate care unit. Respir Med (2005) 1.01

Glucocorticoid treatment in acute lung injury and acute respiratory distress syndrome. Crit Care Clin (2011) 1.01

Noninvasive ventilation for treating acute respiratory failure in AIDS patients with Pneumocystis carinii pneumonia. Intensive Care Med (2002) 0.98

One-year outcomes of community-acquired and healthcare-associated pneumonia in the Veterans Affairs Healthcare System. Int J Infect Dis (2011) 0.97

Double-blind, placebo-controlled pilot randomized trial of methylprednisolone infusion in pediatric acute respiratory distress syndrome. Pediatr Crit Care Med (2015) 0.95

Long-term observational, non-randomized study of enzyme replacement therapy in late-onset glycogenosis type II. J Inherit Metab Dis (2010) 0.95

Sputum color as a marker of acute bacterial exacerbations of chronic obstructive pulmonary disease. Respir Med (2004) 0.93

Prolonged glucocorticoid treatment in acute respiratory distress syndrome: Evidence supporting effectiveness and safety. Crit Care Med (2009) 0.92

Rapid induction of autoantibodies during ARDS and septic shock. J Transl Med (2010) 0.89

An investigation of airway acidification in asthma using induced sputum: a study of feasibility and correlation. Am J Respir Crit Care Med (2007) 0.88

Corticosteroids do not cause harmful increase of viral load in severe H1N1 virus infection. Intensive Care Med (2010) 0.86

The effectiveness of a bronchial drainage technique (ELTGOL) in COPD exacerbations. Respirology (2009) 0.86

Corticosteroids in ARDS: a counterpoint. Chest (2007) 0.86

Inspiratory muscle training for diaphragm dysfunction after cardiac surgery. J Thorac Cardiovasc Surg (2012) 0.84

The role of respiratory management of Pompe disease. Respir Med (2013) 0.84

Critical illness-related corticosteroid insufficiency and community-acquired pneumonia: back to the future! Eur Respir J (2008) 0.81

Is prolonged low-dose glucocorticoid treatment beneficial in community-acquired pneumonia? Curr Infect Dis Rep (2013) 0.80

Iron lung vs mask ventilation in the treatment of acute on chronic respiratory failure in COPD patients: a multicenter study. Chest (2002) 0.80

Metabolic exercise test data combined with cardiac and kidney indexes, the MECKI score: a multiparametric approach to heart failure prognosis. Int J Cardiol (2012) 0.80

Keratin-14 expression in pneumocytes as a marker of lung regeneration/repair during diffuse alveolar damage. Am J Respir Crit Care Med (2014) 0.79

Effectiveness of prolonged glucocorticoid treatment in acute respiratory distress syndrome: the right drug, the right way? Crit Care Med (2006) 0.79

Bosentan for patients with chronic thromboembolic pulmonary hypertension. Eur J Intern Med (2008) 0.78

Improving the 2007 Infectious Disease Society of America/American Thoracic Society severe community-acquired pneumonia criteria to predict intensive care unit admission. J Crit Care (2012) 0.78

Italian registry of patients with alpha-1 antitrypsin deficiency: general data and quality of life evaluation. COPD (2015) 0.77

Methylprednisolone infusion in early severe ARDS results of a randomized controlled trial. 2007. Chest (2009) 0.77

Oxidative stress during exercise: further proof that being lean is detrimental for chronic obstructive pulmonary disease patients. Respiration (2006) 0.76

Glucocorticoid treatment in community-acquired pneumonia without severe sepsis: no evidence of efficacy. Am J Respir Crit Care Med (2010) 0.76

Glucocorticoid treatment in community-acquired pneumonia. Lancet (2011) 0.76

Acute clinical deterioration with increased systemic inflammation as a risk factor for depression: an alternative interpretation of the data. Am J Psychiatry (2012) 0.75

Acute lung injury and acute respiratory distress syndrome. Lancet (2007) 0.75

Sildenafil in pulmonary arterial hypertension. Am J Respir Crit Care Med (2004) 0.75

Evidence-based support for prolonged glucocorticoid treatment in acute lung injury/acute respiratory distress syndrome. Crit Care Med (2011) 0.75

Corticosteroids for community-acquired pneumonia: time to act! Crit Care (2008) 0.75

What conclusions should be drawn between critical care physician management and patient mortality in the intensive care unit? Ann Intern Med (2008) 0.75

Management of patients hospitalised with community-acquired pneumonia: dexamethasone reduces length of stay by 1 day. Evid Based Med (2011) 0.75

Physiological effects of translaryngeal open ventilation in patients with restrictive respiratory disorders. Intensive Care Med (2002) 0.75

[Airways acidification and pathogenesis of asthma]. Recenti Prog Med (2008) 0.75

[Prolonged infusion of hydrocortisone in patients with severe community acquired pneumonia]. Recenti Prog Med (2006) 0.75

Prevalence and prognostic role of cardiovascular complications in patients with exacerbation of chronic obstructive pulmonary disease admitted to Italian respiratory intensive care units. Ital Heart J (2004) 0.75